MedXY
Not signed in Sign in / Register
Skip to content
medxy logo Medxy AI
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • iDoctor
  • Medical Calculators
  • Videos
  • Health Games
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • iDoctor
  • Medical Calculators
  • Videos
  • Health Games

lifestyle medicine

  • Home
  • lifestyle medicine
Synergistic Protection: Combining GLP-1 Receptor Agonists with Lifestyle Habits Slashes Cardiovascular Risk in Type 2 Diabetes
Posted inCardiology Diabetes & Endocrinology news

Synergistic Protection: Combining GLP-1 Receptor Agonists with Lifestyle Habits Slashes Cardiovascular Risk in Type 2 Diabetes

Posted by By MedXY 03/07/2026
A massive cohort study of nearly 100,000 veterans reveals that while GLP-1 receptor agonists significantly reduce MACE, the combination with a healthy lifestyle offers a 43% lower risk, emphasizing the need for integrated cardiometabolic care in Type 2 Diabetes management.
Read More
Beyond the Plate: Mediterranean Lifestyle as a Potent Shield Against Chronic Kidney Disease
Posted inNephrology news Public Health

Beyond the Plate: Mediterranean Lifestyle as a Potent Shield Against Chronic Kidney Disease

Posted by By MedXY 02/05/2026
A large-scale prospective study from the UK Biobank reveals that a comprehensive Mediterranean lifestyle—integrating diet, physical activity, and social connectivity—significantly reduces the risk of incident chronic kidney disease by up to 35%.
Read More
Cardiologists and Lifestyle Medicine: Bridging the Gap Between Recommendation and Practice
Posted inCardiology Clinical Updates Family Medicine & Nutrition news Specialties

Cardiologists and Lifestyle Medicine: Bridging the Gap Between Recommendation and Practice

Posted by By MedXY 08/31/2025
A recent survey reveals that most US cardiologists inconsistently adhere to lifestyle recommendations, especially dietary and physical activity guidelines, despite endorsing them for cardiovascular health.
Read More
Pills vs. Plates: Can Lifestyle Medicine Cure Your Chronic Conditions?
Posted inFamily Medicine & Nutrition news Specialties

Pills vs. Plates: Can Lifestyle Medicine Cure Your Chronic Conditions?

Posted by By MedXY 07/25/2025
Explore the science and practical realities of treating chronic diseases with lifestyle medicine versus conventional pharmaceuticals.
Read More

Take a game break

Explore a few games from MedXY.

Explore all games
  • Exercise as a Cognitive Buffer in Midlife Women: Insights into Domain-Specific Effects and Modality Differences
  • Empowering Safer Mobility Behaviors to Prevent Falls in Parkinson’s Disease: Insights from Clinicians and Researchers
  • Eating Difficulty as a Marker for Broader Functional Vulnerability and Cognitive Decline in Older Adults: Insights from Four Large Ageing Cohorts
  • Izalontamab Brengitecan Shows Promising Efficacy Over Platinum Chemotherapy in EGFR-Mutated NSCLC Post-Third-Generation EGFR TKI Progression
  • Longitudinal Executive Function Development in Very Preterm Children: Persistent Challenges into Adolescence
  • About us
  • Contact us
  • MedXY story
  • Privacy Policy
  • Subscribe Now!

  • English
  • 日本語
  • Tiếng Việt
  • 中文

Alzheimer's disease artificial intelligence atrial fibrillation biomarkers breast cancer Cardiology cardiovascular disease cardiovascular risk case report chronic kidney disease clinical trial clinical trials critical care diabetes epidemiology GLP-1 receptor agonists heart failure hepatocellular carcinoma Hypertension immunotherapy inflammation machine learning MASLD mental health Mortality multiple myeloma myocardial infarction nutrition obesity older adults oncology Pediatrics precision medicine Pregnancy prognosis public health quality of life randomized clinical trial randomized controlled trial risk stratification SGLT2 inhibitors stroke targeted therapy type 1 diabetes type 2 diabetes

Your health, we care

Copyright 2026 — Medxy AI. All rights reserved.
Scroll to Top